Dr Reddy’s Laboratories (DRL)has launched its generic Semaglutide injection in Canada, becoming among the first companies to introduce the product in the Canadian market following regulatory approval from Health Canada. The company said it received the Notice of Compliance (NOC) from Health Canada on April 28, 2026, paving the way for the commercial launch. Canada […]